BlueWillow Biologics' Convertible Note Round

BlueWillow Biologics raised a round of funding on February 04, 2016.

BlueWillow Biologics, formerly NanoBio, is a privately-held biopharmaceutical company, focused on developing and commercializing intranasal vaccines using its patented NanoVax┬« technology platform. T…

Articles about BlueWillow Biologics' Convertible Note Round: